BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 3,985.00
-10.00 (-0.25%)
At close: May 14, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 19.38 billion as of May 15, 2026. Its market cap has decreased by -35.73% in one year.
Market Cap
19.38B
Enterprise Value
23.07B
Revenue
23.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,985.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 19.38B, a decrease of -86.25%. That is a compound annual growth rate of -46.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 19.43B | -15.54% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 474.25B |
| DreamCIS | 182.54B |
| HLB bioStep | 107.65B |
| P&K Skin Research Center | 67.44B |
| WOOJUNG BIO | 49.82B |
| C&R Research | 39.42B |
| DT&CRO CO. | 37.07B |
| SLS BIO | 26.89B |